Farrell Michael J.
Chairman and CEO
In the last 12 months, Farrell Michael J. filed 51 SEC Form 4 transactions across 2 issuers: $0 in open-market purchases and $14.6M in open-market sales. 39% of these transactions were executed under a pre-scheduled Rule 10b5-1 trading plan.
- $0Open-market buys (1y)
- $14.6MOpen-market sells (1y)
- 51Transactions filed
- 2Distinct issuers
- 39%Under Rule 10b5-1
- 2026-10-07Latest filing
Issuers Filed For By open-market buy volume
Recent Form 4 Filings Most recent 51 of 51 (1-year window)
| Date | Ticker | Company | Type | SEC Code | Value | Shares | Price |
|---|---|---|---|---|---|---|---|
| 2026-10-07 | RMD | RESMED INC | Exercise 10b5-1 | M | $730.4K | 4,991 | $146.3 |
| 2026-10-07 | RMD | RESMED INC | Exercise 10b5-1 | M | $0 | 4,991 | $0.0 |
| 2026-10-07 | RMD | RESMED INC | Sell 10b5-1 | S | $1.1M | 4,991 | $226.3 |
| 2026-09-30 | ZBH | ZIMMER BIOMET HOLDINGS, INC. | Grant | A | $0 | 417 | $0.0 |
| 2026-09-08 | RMD | RESMED INC | Exercise 10b5-1 | M | $730.4K | 4,991 | $146.3 |
| 2026-09-08 | RMD | RESMED INC | Exercise 10b5-1 | M | $0 | 4,991 | $0.0 |
| 2026-09-08 | RMD | RESMED INC | Sell 10b5-1 | S | $1.1M | 4,991 | $222.4 |
| 2026-08-14 | RMD | RESMED INC | Grant | A | $0 | 13,547 | $0.0 |
| 2026-08-07 | RMD | RESMED INC | Exercise 10b5-1 | M | $730.4K | 4,991 | $146.3 |
| 2026-08-07 | RMD | RESMED INC | Exercise 10b5-1 | M | $0 | 4,991 | $0.0 |
| 2026-08-07 | RMD | RESMED INC | Sell 10b5-1 | S | $1.0M | 4,991 | $205.7 |
| 2026-07-07 | RMD | RESMED INC | Exercise 10b5-1 | M | $730.4K | 4,991 | $146.3 |
| 2026-07-07 | RMD | RESMED INC | Exercise 10b5-1 | M | $0 | 4,991 | $0.0 |
| 2026-07-07 | RMD | RESMED INC | Sell 10b5-1 | S | $1.1M | 4,991 | $218.5 |
| 2026-06-30 | ZBH | ZIMMER BIOMET HOLDINGS, INC. | Grant | A | $0 | 433 | $0.0 |
| 2026-06-08 | RMD | RESMED INC | Exercise 10b5-1 | M | $730.4K | 4,991 | $146.3 |
| 2026-06-08 | RMD | RESMED INC | Exercise | M | $0 | 4,991 | $0.0 |
| 2026-06-08 | RMD | RESMED INC | Sell 10b5-1 | S | $968.1K | 4,991 | $194.0 |
| 2026-05-22 | ZBH | ZIMMER BIOMET HOLDINGS, INC. | Grant | A | $0 | 875 | $0.0 |
| 2026-05-22 | ZBH | ZIMMER BIOMET HOLDINGS, INC. | Grant | A | $0 | 1,517 | $0.0 |
| 2026-05-07 | RMD | RESMED INC | Exercise 10b5-1 | M | $730.4K | 4,991 | $146.3 |
| 2026-05-07 | RMD | RESMED INC | Exercise 10b5-1 | M | $0 | 4,991 | $0.0 |
| 2026-05-07 | RMD | RESMED INC | Sell 10b5-1 | S | $1.0M | 4,991 | $207.8 |
| 2026-04-07 | RMD | RESMED INC | Exercise 10b5-1 | M | $730.4K | 4,991 | $146.3 |
| 2026-04-07 | RMD | RESMED INC | Exercise 10b5-1 | M | $0 | 4,991 | $0.0 |
| 2026-04-07 | RMD | RESMED INC | Sell 10b5-1 | S | $1.1M | 4,991 | $225.5 |
| 2026-03-31 | ZBH | ZIMMER BIOMET HOLDINGS, INC. | Grant | A | $0 | 421 | $0.0 |
| 2026-03-09 | RMD | RESMED INC | Grant | – | $730.4K | 4,991 | $146.3 |
| 2026-03-09 | RMD | RESMED INC | Grant | – | $0 | 4,991 | $0.0 |
| 2026-03-09 | RMD | RESMED INC | Sell | – | $1.3M | 4,991 | $251.0 |
| 2026-02-09 | RMD | RESMED INC | Grant | – | $730.4K | 4,991 | $146.3 |
| 2026-02-09 | RMD | RESMED INC | Grant | – | $0 | 4,991 | $0.0 |
| 2026-02-09 | RMD | RESMED INC | Sell | – | $1.4M | 4,991 | $273.8 |
| 2026-01-07 | RMD | RESMED INC | Grant | – | $730.4K | 4,991 | $146.3 |
| 2026-01-07 | RMD | RESMED INC | Grant | – | $0 | 4,991 | $0.0 |
| 2026-01-07 | RMD | RESMED INC | Sell | – | $1.2M | 4,991 | $248.5 |
| 2025-12-31 | ZBH | ZIMMER BIOMET HOLDINGS, INC. | Grant | – | $0 | 415 | $0.0 |
| 2025-12-08 | RMD | RESMED INC | Grant | – | $730.4K | 4,991 | $146.3 |
| 2025-12-08 | RMD | RESMED INC | Grant | – | $0 | 4,991 | $0.0 |
| 2025-12-08 | RMD | RESMED INC | Sell | – | $1.3M | 4,991 | $251.4 |
| 2025-11-24 | RMD | RESMED INC | Grant | – | $8.3M | 33,288 | $250.5 |
| 2025-11-20 | RMD | RESMED INC | Grant | – | $0 | 13,551 | $0.0 |
| 2025-11-20 | RMD | RESMED INC | Grant | – | $0 | 7,297 | $0.0 |
| 2025-11-11 | RMD | RESMED INC | Grant | – | $558.1K | 2,232 | $250.1 |
| 2025-11-11 | RMD | RESMED INC | Grant | – | $865.2K | 3,459 | $250.1 |
| 2025-11-11 | RMD | RESMED INC | Grant | – | $551.6K | 2,206 | $250.1 |
| 2025-11-07 | RMD | RESMED INC | Grant | – | $99.9K | 983 | $101.6 |
| 2025-11-07 | RMD | RESMED INC | Grant | – | $714.3K | 7,028 | $101.6 |
| 2025-11-07 | RMD | RESMED INC | Grant | – | $0 | 983 | $0.0 |
| 2025-11-07 | RMD | RESMED INC | Grant | – | $0 | 7,028 | $0.0 |
| 2025-11-07 | RMD | RESMED INC | Sell | – | $2.0M | 8,011 | $249.8 |
Methodology & FAQ
How These Filings Are Sourced
All transactions on this page are sourced directly from SEC EDGAR. A complete description of the open-market vs grant distinction, the Rule 10b5-1 plan-reference heuristic, and the per-insider name matching is documented in the Methodology.
What companies does Farrell Michael J. file Form 4 disclosures for?
Farrell Michael J. has filed SEC Form 4 transactions for 2 issuers in the last 12 months: RESMED INC (RMD), ZIMMER BIOMET HOLDINGS, INC. (ZBH).
What does the 10b5-1 badge mean on these transactions?
Rule 10b5-1 is an SEC rule that lets insiders schedule trades in advance under a written plan, providing an affirmative defense against insider-trading allegations as long as the plan was adopted in good faith and not while in possession of material non-public information. Of Farrell Michael J.'s 51 reported transactions in the last 12 months, 20 (39%) reference a 10b5-1 trading plan in the Form 4 footnotes.
Are these all the transactions Farrell Michael J. has executed?
This page shows SEC Form 4 transactions on record in Pactolio's tracked universe for the last 12 months. Form 4 only covers transactions in registered classes of equity at issuers where the person qualifies as an insider (officer, director, or 10% beneficial owner). Trades in funds, foreign issuers, or non-insider positions are not disclosed under Form 4 and are not included here.